Biophotonics Market

Biophotonics Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The biophotonics market size is expected to reach US$ 168.07 Billion by 2032.

The biophotonics market is expected grow at a CAGR of 10.6% from 2023 to 2032.

The biophotonics market size was estimated to be US$ 61.37 Billion in 2022.

The global biophotonics market is being driven by several factors such as the rising prevalence of chronic diseases, advancements in technology, and increasing demand for diagnostic procedures.

North America is the largest market for biophotonics. The increasing prevalence of chronic diseases and the growing demand for non-invasive diagnostic tools are also driving the growth of the biophotonics market in North America.

Medical diagnostics is the largest application segment in the biophotonics market. This is because the field of medical diagnostics is rapidly evolving, and the demand for accurate and non-invasive diagnostic tools is increasing globally.

The United States being the largest contributor to the growth of the biophotonics market in the North America.

Affymetrix Inc., Agilent Technologies Inc., Becton, Dickinson and Company, Carl Zeiss AG Coherent Inc., Hamamatsu Photonics KK, Lumenis Ltd., Newport Corporation, Olympus Corporation, PerkinElmer Inc., Photonics GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Zecotek Photonics Inc., ZEISS International among others, are the major players in this market.